Issue 5, 2016

The evolution of drug discovery: from phenotypes to targets, and back

Abstract

Cumulative scientific and technological advances over the past two centuries have transformed drug discovery from a largely serendipitous process into the high tech pipelines of today. For thousands of years, medicines were sourced directly from nature, through observing the phenotypic effects of substances on humans or animals. Following the molecular biology revolution and initiation of the human genome project in the 1990s, target-based screening gained popularity and soon came to dominate the pharmaceutical industry. Two decades later, the phenotypic approach began to make a strong comeback, benefiting from the scalability and speed afforded by massive technological advances. This has ignited a debate over the relative productivities of phenotypic and target-based screening. However, as more integrative technologies become available, the focus of the discussion should shift from prioritizing the different approaches to finding strategies that can combine their complementary strengths. This review chronicles major trends and transformative events in the evolution of drug discovery, and underscores the importance of phenotypic approaches for past, and likely future, successes.

Graphical abstract: The evolution of drug discovery: from phenotypes to targets, and back

Article information

Article type
Review Article
Submitted
02 Mar 2016
Accepted
24 Mar 2016
First published
30 Mar 2016

Med. Chem. Commun., 2016,7, 788-798

The evolution of drug discovery: from phenotypes to targets, and back

H. Al-Ali, Med. Chem. Commun., 2016, 7, 788 DOI: 10.1039/C6MD00129G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements